NRAS and melanoma: Specifically, we examine the impact of AKT inhibition on these clusters, showing that disruption of AKT activity alters the organization of NRas-PI3K nanoclusters, thereby providing insights into the regulatory mechanisms controlling melanoma cell signaling.